Ticker Details
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
IPO Date:	September 11, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$344.94M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 2.51%
Avg Daily Range (30 D):	$0.26 | 3.63%
Avg Daily Range (90 D):	$0.19 | 2.66%

Institutional Daily Volume
Avg Daily Volume:	.09M
Avg Daily Volume (30 D):	.22M
Avg Daily Volume (90 D):	.16M

Trade Size
Avg Trade Size (Sh.):	122
Avg Trade Size (Sh.) (30 D):	72
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	44
Avg Institutional Trade:	$2.84M
Avg Institutional Trade (30 D):	$4.54M
Avg Institutional Trade (90 D):	$2.92M
Avg Institutional Trade Volume:	.35M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$5.53M
Avg Closing Trade (30 D):	$1.81M
Avg Closing Trade (90 D):	$1.81M
Avg Closing Volume:	676.71K

News

Dec 26, 2025 @ 10:44 PM Southpoint holdings in Fennec Pharmaceuticals Inc.... Source: Na

Nov 14, 2025 @ 4:11 AM Fennec Pharmaceuticals Announces Private Offering ... Source: Fennec Pharmaceuticals Inc.

Nov 14, 2025 @ 4:07 AM Fennec Pharmaceuticals Announces Pricing of Offeri... Source: Fennec Pharmaceuticals Inc.

Aug 14, 2025 @ 3:04 PM Fennec Q2 Sales Jump 33 Percent Source: Na

Jun 3, 2025 @ 8:31 PM Fennec Announces Results of Annual Meeting Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.01	$-.16	$-.34
Diluted EPS	$.01	$-.16	$-.34
Revenue	$15.11M	$13.78M	$44.64M
Gross Profit
Net Income / Loss	$.2M	$-4.79M	$-9.74M
Operating Income / Loss	$-.12M	$-2.55M	$-6.28M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Sep 05, 2014	1:3
Aug 30, 2011	1:18
Aug 02, 2005	1:5